Natural killer cell derived Extracellular Vesicles: promising candidate in cancer therapy

سال انتشار: 1400
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 168

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CANCERMED05_135

تاریخ نمایه سازی: 27 دی 1400

چکیده مقاله:

Introduction: Ovarian cancer is the fifth most lethal cancer in women. According to the low efficiency of common therapies and also high rate of cancer recurrence, developing a new effective therapy is greatly in demand. Natural Killer Cells and Natural Killer Cell derived Extracellular Vesicles (NK-EVs) have therapeutic potential in cancer therapy. Therefore, in this study we have evaluated cytotoxic effect of natural killer cell derived extracellular vesicles on SKOV۳ cells in ovarian cancer. Methods: First, NK cells were activated by adding IL۱۵ (۱۰ ng/ml). Then, culture supernatant was harvested after ۲۴ h by centrifugation at ۲۰۰۰ rpm for ۵ min to remove cells. Different fractions of NK-EVs were isolated by differential centrifugation at ۲۰۰۰g, ۱۰۰۰۰g and ۲۰۰۰۰g respectively. SKOV۳ cells were treated with NK-EVs. Cytotoxicity of the NK-EV was evaluated using MTS assay. The study groups were ۲۰۰۰g NK-EV treatment group, ۱۰۰۰۰g NK-EV (large EV/lEV) treatment group, ۲۰۰۰۰g NK-EV (medium EV/mEV) treatment group, NK cell derived conditioned medium and control group. Results: According to MTS results, mEVs have the highest cytotoxic effect on SKOV۳ cells. Conclusion: NK-EVs have cytotoxic effect on SKOV۳ cells in vitro. NK-EV is considered as an off-the-shelf product and easy to use and store for a long time. Therefore, it could be a great cancer therapy strategy in the future.

کلیدواژه ها:

Ovarian cancer ، SKOV۳ cell line ، Natural Killer cell derived Extracellular Vesicles

نویسندگان

Saba Modanloo

Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran

Seyed Jalal Zargar

Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran

Neda Parvini

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran- Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan Unive

Maryam Shahhoseini

Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

Elham Amirchaghmaghi

Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran- Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute

Faezeh Shekari

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran